• bioXXmed moved to delist its shares from Frankfurt’s Basic Board, terminating the Freiverkehr inclusion.
• The company will send the termination notice to Deutsche Börse on July 16.
• Trading is set to end on Oct. 31, 2026, when the three-month notice period expires.
• Shareholders can continue trading the stock on Frankfurt’s Freiverkehr until the last trading day before Oct. 31.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioXXmed AG published the original content used to generate this news brief via pressetext (Ref. ID: 202607160645PRESSTXTEUPR__DE94DFB5D3D683BB269B5079876E0B5A6) on July 16, 2026, and is solely responsible for the information contained therein.